Companies / ELI LILLY & Co

ELI LILLY & Co

NYSE: LLYCIK 59478Health CareINDIANAPOLIS, INlilly.com ↗
Randall L. Tobias
Chief Executive Officer
Randall L. Tobias
Photo: http://2001-2009.state.gov/r/pa/ei/biog/26580.htm · Public domain · Wikimedia Commons

Financials · FY2025

Revenue$65.18B
Net income$20.64B
Total debt$54.91B
Cash$8.95B
Diluted EPS$22.95
Shares outstanding941.4M

Ownership

941.4M shares outstanding · as of Aug 3, 2026
0.12%Insiders
Ownership
Insiders0.12%1,147,136
10%+ / strategic9.76%91,896,978
Institutions74.48%701,083,523
Public float15.64%147,229,428

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 19

View all →
Insider% of sharesShares
Lilly Endowment, Inc.10% owner
9.76%91,896,978
Ricks David ACEOPresident, Chair, and CEO · Director
0.06%571,715
Skovronsky DanielEVP, CS&PO & Pres. LRL
0.02%160,072
Fyrwald J ErikDirector
<0.01%75,401
Jonsson PatrikEVP & President, LLY Int'l
<0.01%60,647
Alvarez RalphDirector
<0.01%55,723
Hernandez EdgardoEVP & Pres., Mfg. Operations
<0.01%46,096
Yuffa IlyaEVP&Pres, LLY USA&Global Capab
<0.01%32,304
Van Naarden JacobEVP,Pres LLY Oncology&HdCorpBD
<0.01%26,626
Rau DiogoEVP & CIDO
<0.01%26,230

Institutional holders 4,415

View all →
HolderValue% of shares
Lilly Endowment, Inc.$99.08B9.79%
Vanguard Group Inc$88.09B8.71%
BlackRock, Inc.$81.01B7.17%
The PNC Financial Services Group, Inc.$61.56B5.45%
State Street Corporation$43.44B3.85%
Fmr LLC$27.64B2.73%
Capital Research Global Investors$26.40B2.61%
Geode Capital Management, LLC$18.51B2.14%
Morgan Stanley$16.76B1.66%
Capital World Investors$16.15B1.60%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 7, 2026Lilly Endowment, Inc.
10% owner
SellCommon Stock$45.19M-41K
-0.04%
92,023,036
9.78% of shares
high
Feb 9, 2026Ricks David A
CEO
GrantCommon Stock$40.65M+39K
+7.30%
571,715
0.06% of shares
low
Jan 7, 2026Lilly Endowment, Inc.
10% owner
SellCommon Stock$37.96M-34K
-0.04%
92,063,992
9.78% of shares
high
Jan 7, 2026Lilly Endowment, Inc.
10% owner
SellCommon Stock$26.93M-24K
-0.03%
91,977,632
9.77% of shares
high
Jan 7, 2026Lilly Endowment, Inc.
10% owner
SellCommon Stock$23.24M-21K
-0.02%
92,001,994
9.77% of shares
high
Jan 7, 2026Lilly Endowment, Inc.
10% owner
SellCommon Stock$22.76M-21K
-0.02%
92,098,426
9.78% of shares
high
Jan 7, 2026Lilly Endowment, Inc.
10% owner
SellCommon Stock$22.48M-20K
-0.02%
92,134,031
9.79% of shares
high
Jan 7, 2026Lilly Endowment, Inc.
10% owner
SellCommon Stock$18.44M-17K
-0.02%
91,947,281
9.77% of shares
high

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
Lilly Endowment, Inc.Passive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
LLY——532457108—